{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:34:32Z","timestamp":1779302072047,"version":"3.51.4"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"McGill CAS Research Support Program"},{"name":"Kimberly Sue McCall Award in IBD Research","award":["WI230654"],"award-info":[{"award-number":["WI230654"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patients with Crohn\u2019s disease [CD] and ulcerative colitis [UC] are at increased risk for colorectal dysplasia [CRD] and colorectal cancer [CRC]. Adherence to CRC surveillance guidelines is reportedly low internationally.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To evaluate surveillance practices at the tertiary IBD Center of the McGill University Health Center [MUHC] and to determine CRD\/CRC incidence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A representative inflammatory bowel disease cohort with at least 8 years of disease duration [or with primary sclerosing cholangitis] who visited the MUHC between July 1 and December 31, 2016 were included. Adherence to surveillance guidelines was compared to modified 2010 British Society of Gastroenterology guidelines. Incidence rates of CRC, high-grade dysplasia [HGD], low-grade dysplasia [LGD] and colorectal adenomas [CRA] were calculated based on pathology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 1356 CD and UC patients (disease duration: 12 [interquartile range: 6\u201322) and 10 [interquartile range: 5\u201319] years) were identified. The surveillance cohort consisted of 680 patients [296 UC and 384 CD]. Adherence to surveillance guidelines was 76\/82% in UC\/colonic CD. An adequate number of biopsies were taken in 54\/54% of UC\/colonic CD patients. The incidence of CRC\/HGD in UC and CD with colonic involvement was 19.5\/58.5 and 25.1\/37.6 per 100,000 patient-years, respectively. The incidence of dysplasia before 8 years of disease duration was low in both UC\/CD [19.5 and 12.5\/100,000 patient-years] with no CRC detected. The CRA rate was 30\/38% in UC\/colonic CD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High adherence to surveillance guidelines and low CRC and dysplasia, but not CRA rates were found, suggesting that adhering to updated, stratified, surveillance recommendations may result in low advanced neoplasia rates. The incidence of dysplasia before the start of surveillance was low.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjz066","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T18:13:40Z","timestamp":1553710420000},"page":"1343-1350","source":"Crossref","is-referenced-by-count":20,"title":["High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance"],"prefix":"10.1093","volume":"13","author":[{"given":"Kelita","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Al Khoury","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Kurti","sequence":"additional","affiliation":[{"name":"1st Department of Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorant","family":"Gonczi","sequence":"additional","affiliation":[{"name":"1st Department of Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Reinglas","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Verdon","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Kohen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-1910","authenticated-orcid":false,"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqqas","family":"Afif","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Wild","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Seidman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Bitton","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L","family":"Lakatos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University, Montreal QC, Canada"},{"name":"1st Department of Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"key":"2019092705515279400_CIT0001","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2012.01.010","article-title":"Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies","volume":"10","author":"Jess","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019092705515279400_CIT0002","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","article-title":"Increased risk of intestinal cancer in Crohn\u2019s disease: a meta-analysis of population-based cohort studies","volume":"100","author":"Jess","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2019092705515279400_CIT0003","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"2019092705515279400_CIT0004","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2005.12.035","article-title":"Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis","volume":"130","author":"Rutter","year":"2006","journal-title":"Gastroenterology"},{"key":"2019092705515279400_CIT0005","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s10620-015-3979-z","article-title":"Colorectal cancer screening in inflammatory bowel disease","volume":"61","author":"Sengupta","year":"2016","journal-title":"Dig Dis Sci"},{"key":"2019092705515279400_CIT0006","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2019092705515279400_CIT0007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"2019092705515279400_CIT0008","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.gie.2017.07.028","article-title":"Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis","volume":"86","author":"Flores","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"2019092705515279400_CIT0009","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.cgh.2015.04.185","article-title":"Detection of dysplasia or cancer in 3.5% of patients with inflammatory bowel disease and colonic strictures","volume":"13","author":"Fumery","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019092705515279400_CIT0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies","volume":"28","author":"Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2019092705515279400_CIT0011","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years","volume":"143","author":"Jess","year":"2012","journal-title":"Gastroenterology"},{"key":"2019092705515279400_CIT0012","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies","volume":"100","author":"Velayos","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2019092705515279400_CIT0013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ajg.2010.428","article-title":"The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study","volume":"106","author":"Baars","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2019092705515279400_CIT0014","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/gut.2011.237412","article-title":"Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease","volume":"61","author":"van Schaik","year":"2012","journal-title":"Gut"},{"key":"2019092705515279400_CIT0015","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie","year":"2015","journal-title":"N Engl J Med"},{"key":"2019092705515279400_CIT0016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2036.2006.03062.x","article-title":"Review article: colorectal cancer surveillance in ulcerative colitis - what should we be doing?","volume":"24","author":"Obrador","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2019092705515279400_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crohns.2012.09.005","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations","volume":"7","author":"Van Assche","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2019092705515279400_CIT0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"key":"2019092705515279400_CIT0021","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1053\/j.gastro.2004.03.025","article-title":"Diagnosis and management of dysplasia in patients with inflammatory bowel diseases","volume":"126","author":"Itzkowitz","year":"2004","journal-title":"Gastroenterology"},{"key":"2019092705515279400_CIT0023","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.gastro.2016.08.002","article-title":"Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer","volume":"151","author":"Watanabe","year":"2016","journal-title":"Gastroenterology"},{"key":"2019092705515279400_CIT0024","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.gie.2006.09.025","article-title":"Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?","volume":"65","author":"Rubin","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"2019092705515279400_CIT0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"2019092705515279400_CIT0026","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"2019092705515279400_CIT0029","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1155\/2009\/691850","article-title":"Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital","volume":"23","author":"Kottachchi","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"2019092705515279400_CIT0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10350-003-0049-y","volume":"47","author":"Gearry","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"2019092705515279400_CIT0032","first-page":"438","article-title":"Random versus targeted biopsies for colorectal cancer surveillance in inflammatory bowel disease","volume":"6","author":"Ahmed","year":"2010","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2019092705515279400_CIT0032a","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2007-962987","article-title":"Surveillance colonoscopy in ulcerative colitis patients in Germany","volume":"45","author":"Kaltz","year":"2007","journal-title":"Z Gastroenterol"},{"key":"2019092705515279400_CIT0033","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0016-5085(92)91185-7","article-title":"DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis","volume":"103","author":"Rubin","year":"1992","journal-title":"Gastroenterology"},{"key":"2019092705515279400_CIT0034","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0016-5107(00)70405-6","article-title":"How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance","volume":"51","author":"Eaden","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"2019092705515279400_CIT0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ajg.2011.93","article-title":"Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences","volume":"109","author":"van den Broek","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2019092705515279400_CIT0036","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/gut.2008.169714","article-title":"Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity","volume":"58","author":"Awais","year":"2009","journal-title":"Gut"},{"key":"2019092705515279400_CIT0037","first-page":"616","article-title":"Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?","volume":"67","author":"Moussata","year":"2018","journal-title":"Gut"},{"key":"2019092705515279400_CIT0038","volume-title":"Colorectal Cancer Statistics","author":"Canadian Cancer Society","year":"2017"},{"key":"2019092705515279400_CIT0039","article-title":"SEER Cancer Statistics Review","author":"Noone"},{"key":"2019092705515279400_CIT0040","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-314190","article-title":"Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study","author":"Choi","year":"2019;68:414\u2013422","journal-title":"Gut"},{"key":"2019092705515279400_CIT0041","first-page":"639","article-title":"Risk of colorectal cancer in patients with ulceratirve colitis: a meta-analysis of population-based cohort studies","volume":"10","author":"Soderlund","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019092705515279400_CIT0042","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cgh.2012.09.026","article-title":"Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010","volume":"11","author":"Jess","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019092705515279400_CIT0043","first-page":"304","article-title":"Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: past, present, and future","volume":"11","author":"Naymagon","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2019092705515279400_CIT0044","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2015.01.031","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"148","author":"Laine","year":"2015","journal-title":"Gastroenterology"},{"key":"2019092705515279400_CIT0046","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"2019092705515279400_CIT0047","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ajg.2015.130","article-title":"Low prevalence of colon polyps in chronic inflammatory conditions of the colon","volume":"110","author":"Sonnenberg","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2019092705515279400_CIT0048","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2036.2004.01914.x","article-title":"Adenomatous colonic polyps are rare in ulcerative colitis","volume":"19","author":"Kitiyakara","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2019092705515279400_CIT0049","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/pgmj.2005.033779","article-title":"Distal adenomatous polyps are rare in patients with inflammatory bowel disease","volume":"82","author":"Dixon","year":"2006","journal-title":"Postgrad Med J"},{"key":"2019092705515279400_CIT0050","first-page":"215","article-title":"Rarity of adenomatous polyps in ulcerative colitis and its implications for colonic carcinogenesis","volume":"48","author":"Ben-Horin","year":"2016","journal-title":"Endoscopy"},{"key":"2019092705515279400_CIT0051","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.3748\/wjg.14.3937","article-title":"Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies","volume":"14","author":"Lakatos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2019092705515279400_CIT0052","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"2019092705515279400_CIT0053","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjx180.606","article-title":"Quality of care and outcomes in a tertiary hospital inflammatory bowel disease (IBD) centre: monitoring and treatment algorithms during follow-up.","author":"Kurti","year":"2018","journal-title":"13th Congress of the European Crohn\u2019s and Colitis Organization"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjz066\/28566371\/jjz066.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/13\/10\/1343\/30048060\/jjz066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T05:52:26Z","timestamp":1569563546000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/13\/10\/1343\/5421121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,3,28]]},"published-print":{"date-parts":[[2019,9,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz066","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,3,28]]}}}